(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Exu phosphorylation is required for bicoid mRNA localisation and
embryonic patterning. (A-E) In situ hybridisation showing bicoid mRNA
(red) in confocal sections of stage 9 (left) and stage 10b (right) egg
chambers. DNA is shown in green. Wild-type (A) or mutant (B-E) Exu protein was
expressed from transgenes in an exu-null mutant background
(exuXL/exuVL). Sequences of site A and
B are indicated, and mutations are shown in red. All mutations affect
bicoid mRNA localisation at stage 9 (B-E). bicoid mRNA
localisation defects recover at stage 10b when only site A or B is mutant
(B,C), and partially recovers when serines 438, 440 and 457 are mutant (D). No
recovery is observed when all relevant serines in site A and B are
simultaneously mutated. (A'-E') Embryos in the right panel are
derived from females of the same genotype as egg chambers in the left panel.
Embryos were stained with anti-Eve antibody to visualise segmentation. Ten
embryos from each genotype were randomly chosen for analysis with the light
microscope. Those embryos that show maximal anterior extension of the first
Eve stripe are shown. The average position of the first Eve stripe of the ten
analysed embryos is indicated as percentage of egg length. The average
position of the first Eve stripe in exu null mutants
(exuXL/exuVL) is at 26.9% egg length. Black
line indicates the position of first Eve stripe in embryos expressing wild
type Exu. The extension of the anterior shift of the first Eve stripe in the
mutants (B'-E') corresponds to the severity of the bicoid
mRNA localisation defects during oogenesis (B-E). All females were grown at
18°C. Anterior is leftwards; posterior is rightwards.